MedTrace Logo

Pilot Evaluation of a New Galyfilcon A Lens Prototype and Enfilcon A Lens

NCT01192542 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2018-06-19

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the visual acuity, limbal and bulbar redness of the new galyfilcon A prototype lenses against Avaira® lenses when worn as daily wear for seven (7) days.

Conditions

  • Myopia

Interventions

DEVICE

galyfilcon A prototype lens

Prototype silicone hydrogel contact lens

DEVICE

enfilcon A lens

Marketed silicone hydrogel contact lens

Sponsors & Collaborators

  • Johnson & Johnson Vision Care, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2010-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01192542 on ClinicalTrials.gov